Citation Impact
Citing Papers
Cancer treatment and survivorship statistics, 2022
2022 Standout
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis
2010
Anti-Müllerian hormone (AMH): Regulator and marker of ovarian function
2010
Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?
2010
Thyroid cancer
2016 Standout
Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
2012
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study
2008
Rethinking mechanisms, diagnosis and management of endometriosis
2019 Standout
Granulosa Cell Production of Anti-Müllerian Hormone Is Increased in Polycystic Ovaries
2006
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome
2008
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization
2008
Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review
2016
Fertility and infertility: Definition and epidemiology
2018 Standout
Is foetal hyperexposure to androgens a cause of PCOS?
2017
Polycystic Ovary Syndrome and Oocyte Developmental Competence
2008
Executive summary of the Stages of Reproductive Aging Workshop + 10
2012 Standout
Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features
2012
Serum Anti-Müllerian Hormone as a Surrogate for Antral Follicle Count for Definition of the Polycystic Ovary Syndrome
2006
Antimüllerian hormone as a predictor of controlled ovarian hyperstimulation outcome: comparison of two commercial immunoassay kits
2011
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Reconciling the Definitions of Polycystic Ovary Syndrome: The Ovarian Follicle Number and Serum Anti-Müllerian Hormone Concentrations Aggregate with the Markers of Hyperandrogenism
2010
Anti-Mullerian hormone (AMH): what do we still need to know?
2009
Polycystic ovary syndrome
2016 Standout
Can Anti-Müllerian Hormone Predict the Diagnosis of Polycystic Ovary Syndrome? A Systematic Review and Meta-Analysis of Extracted Data
2013
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Anti-Mullerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome
2009
Anti-Mullerian hormone: a new marker for ovarian function
2005
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Anti-MüLlerian Hormone as a Marker of Ovarian Reserve: An Update
2008
Cancer treatment and survivorship statistics, 2019
2019 Standout
Changes in Serum Anti-Mullerian Hormone Level during Low-Dose Recombinant Follicular-Stimulating Hormone Therapy for Anovulation in Polycystic Ovary Syndrome
2007
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
2016
Works of Baruch Brooks being referenced
Serum inhibin A, VEGF and TNFα levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial
2006
Preimplantation genetic diagnosis (PGD) – prevention of the birth of children affected with endocrine diseases
2011
Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism
2005
Neonatal outcome after preimplantation genetic diagnosis
2014